Drugs, devices, biologics, and procurement — unified on one canonical entity graph, and answerable in plain language. Built India-first, structurally global.
Three intelligence rails and a procurement workflow, each a reference layer in its own right — and one synthesis layer that reads across the rails.
The synthesis layer over the three intelligence rails. Ask one question across drug, biologic, and device data — and get an answer traced to the source record. Procurement decisions in Procure draw on the same canonical graph; private hospital data never enters OushIQ.
A single company resolves to its drugs, its biologics, its devices, and its procurement footprint — across India's national registries and global regulators. That graph is what no single-source database carries, and what makes a cross-domain question answerable at all.
Live-verified counts across the rails. India is the source-of-truth market; global is the reach.
Move from a device to landed cost, sourcing, and tier requirements — with classification mapped.
Open Procure →Resolve a molecule's safety, pricing, regulatory status, and competitive position across rails.
Explore the IQ family →One question across drug, biologic, and device intelligence — answered with cited records.
Open OushIQ →Closed-by-default data architecture, published policies, and provenance on every figure. Customer data is isolated by tenant: a hospital's records never leave its account and are never shared or sold — only de-identified, aggregated market benchmarks flow back. Compliance roadmap in flight.